✦ LIBER ✦

Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation

✍ Scribed by Yoshihide Ueda; Hiroyuki Marusawa; Toshimi Kaido; Yasuhiro Ogura; Kohei Ogawa; Atsushi Yoshizawa; Koichiro Hata; Yasuhiro Fujimoto; Norihiro Nishijima; Tsutomu Chiba; Shinji Uemoto

Book ID: 114944030
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 165 KB
Volume: 43
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2012.01020.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis of hepatitis B recurrence af

Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin

✍ S Engler; P Sauer; E Klar; W Stremmel; B Kallinowski 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The role of entecavir in preventing hepa

The role of entecavir in preventing hepatitis B recurrence after liver transplantation

✍ Zhi Feng XI; Qiang XIA; Jian Jun ZHANG; Xiao Song CHEN; Long Zhi HAN; Xin WANG; 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 125 KB

Prevention of hepatitis B virus recurren

Prevention of hepatitis B virus recurrence after living donor liver transplantation

✍ H. Ali; H. Egawa; K. Uryuhara; K. Ogawa; M. Kasahara; M. Ueda; H. Marusawa; M. N 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Prevention of hepatitis B recurrence aft

Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis

✍ Shusen Zheng; Yaomin Chen; Tingbo Liang; Anwei Lu; Weilin Wang; Yan Shen; Min Zh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

The aim of our study was to determine the outcomes of liver transplant recipients receiving either lamivudine (LAM) monotherapy or LAM combined with low-dose intramuscular (IM) hepatitis B Immunoglobulin (HBIG) therapy. We performed a retrospective review of the medical records of patients that had

Efficacy, safety and pharmacokinetic pro

Efficacy, safety and pharmacokinetic profile of pasteurized intramuscular anti-hepatitis B immunoglobulin for the prophylaxis of hepatitis B virus recurrence after liver transplantation

✍ F. Filipponi; P. Carrai; P. De Simone; A. Franchello; R. Romagnoli; M. Salizzoni 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Prevention of hepatitis B recurrence aft

Prevention of hepatitis B recurrence after living donor liver transplantation: Primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy

✍ Shin Hwang; Sung-Gyu Lee; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

The prevention of hepatitis B virus (HBV) recurrence is essential after liver transplantation in patients infected with HBV. We evaluated the efficacy of primary high-dose hepatitis B immunoglobulin (HBIG) monotherapy and rescue antiviral therapy in 639 HBV-infected adult patients who underwent livi